ID: ALA4473353

Max Phase: Preclinical

Molecular Formula: C24H25ClF3N5O2

Molecular Weight: 471.48

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl

Standard InChI:  InChI=1S/C24H24F3N5O2.ClH/c1-2-4-16-13-17(21-30-22(34-31-21)19-5-3-12-32(19)23(28)29)8-11-20(16)33-14-15-6-9-18(10-7-15)24(25,26)27;/h2,6-11,13,19H,1,3-5,12,14H2,(H3,28,29);1H/t19-;/m0./s1

Standard InChI Key:  VXZXHBSDHBGGAP-FYZYNONXSA-N

Associated Targets(Human)

Sphingosine kinase 2 1579 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sphingosine kinase 1 1990 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Saccharomyces cerevisiae 19171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 471.48Molecular Weight (Monoisotopic): 471.1882AlogP: 5.09#Rotatable Bonds: 7
Polar Surface Area: 101.26Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.17CX LogP: 5.86CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: -1.00

References

1. Sibley CD, Morris EA, Kharel Y, Brown AM, Huang T, Bevan DR, Lynch KR, Santos WL..  (2020)  Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.,  63  (3): [PMID:31895563] [10.1021/acs.jmedchem.9b01508]

Source